Overcoming “RSV identity crisis,” Moderna announced data for its investigational mRNA-1083 vaccine, BWC0977 effort to target drug-resistant pathogens, and more this week from Contagion.
Israel’s Hepatitis C Elimination Program is Making Strides
World Hepatitis Day: Where Do We Go From Here?
Investigational Combination Hepatitis C Therapy Demonstrates a 97% Sustained Virologic Response
Vaccine Equality vs Equity with Dr. Jacinda Abdul-Mutakabbir
Study Finds Association Between Illicit Fentanyl Use and Increased Risk of Hepatitis C
Efficacy of 8-Week Daclatasvir-Sofosbuvir Regimen for Chronic Hepatitis C